ALTL - Beating COVID-19 With The Pacer BioThreat Strategy ETF (Podcast)

• Rushed to market just 6 months into the COVID-19 pandemic, the Pacer BioThreat Strategy ETF (VIRS) takes a unique approach to picking potential pandemic winners.
• The LifeSci BioThreat Strategy Index underlying VIRS selects holdings based on seven different criteria - everything from potential vaccine makers to companies powering the transition to a work-from-home economy.
• Pacer ETFs President Sean O’Hara joins the podcast to explain why his firm's newest fund is designed to protect investor portfolios from pandemics, both present and future.

For further details see: